| Dart Mining NL (DTM) ORDINARY FULLY PAID |
Materials |
$7 |
Change in substantial holding
|
28 Oct 2025 9:08AM |
$0.065 |
$0.033 |
fallen by
49.23%
|
|
| Morphic Ethical Equities Fund Limited (MEC) ORDINARY FULLY PAID |
Financials |
$35 |
Update - Notification of buy-back - MEC
|
28 Oct 2025 9:08AM |
$1.185 |
$1.125 |
fallen by
5.06%
|
|
| Superloop Limited (SLC) ORDINARY FULLY PAID |
Communication Services |
$1,657 |
Correction of Notice of 2025 Annual General Meeting
|
28 Oct 2025 9:08AM |
$3.140 |
$3.220 |
risen by
2.55%
|
|
| EZZ Life Science Holdings Limited (EZZ) ORDINARY FULLY PAID |
Health Care |
$41 |
Annual General Meeting - Letter to Shareholders
|
28 Oct 2025 9:08AM |
$3.320 |
$0.880 |
fallen by
73.49%
|
|
| Peel Mining Limited (PEX) ORDINARY FULLY PAID |
Materials |
$121 |
Quarterly Activities/Appendix 5B Cash Flow Report
|
28 Oct 2025 9:08AM |
$0.105 |
$0.140 |
risen by
33.33%
|
|
PEX - Price-sensitive ASX Announcement
Full Release
Key Points
- Peel Mining Limited held a cash balance of $1.5 million at the end of the September 2025 quarter.
- The company reported a net cash outflow of $750,000 from operating activities including employee and administration costs.
- Investing activities resulted in a $1.05 million outflow, mainly due to metallurgical drilling and acquisition of Vivigani Station.
- Peel Mining raised $16.25 million through a share placement and Share Purchase Plan (SPP), with a successful settlement of Tranche 1 in October 2025.
- The company expects to receive an additional $18.3 million in net proceeds during the December 2025 quarter, subject to shareholder approval.
- New management appointments include Nick Woolrych as Managing Director & CEO, and Ronnie Beevor as Non-Executive Chairman.
- Exploration activities included diamond drilling for metallurgical test work at Wagga Tank, with further drilling expected.
- Peel Mining's strategic focus is shifting from standalone processing to regional processing and consolidation opportunities in the Cobar Basin.
- The company completed the issuance of 58,824,455 new shares from the SPP on 23 October 2025.
- Peel Mining's assets are well-positioned within the Cobar Basin, with low third-party royalties or obligations, supporting future development plans.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Sunshine Metals Limited (SHN) ORDINARY FULLY PAID |
Materials |
$75 |
Appendix 5B Cash Flow Report
|
28 Oct 2025 9:07AM |
$0.024 |
$0.029 |
risen by
20.83%
|
|
SHN - Price-sensitive ASX Announcement
Full Release
Key Points
- Net cash flow from operating activities was negative $234,000.
- Investing activities resulted in a cash outflow of $1,221,000.
- Financing activities generated $4,594,000 in net cash inflow.
- Cash and cash equivalents at the end of the period were $5,057,000.
- The report is compliant with ASX Listing Rules.
- The report was authorized by the board of Sunshine Metals Limited.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| EZZ Life Science Holdings Limited (EZZ) ORDINARY FULLY PAID |
Health Care |
$41 |
Notice of Annual General Meeting/Proxy Form
|
28 Oct 2025 9:07AM |
$3.320 |
$0.880 |
fallen by
73.49%
|
|
| CSL Limited (CSL) ORDINARY FULLY PAID |
Health Care |
$69,493 |
CSL 2025 AGM Chair and CEO Speech and Presentation
|
28 Oct 2025 9:07AM |
$211.420 |
$143.190 |
fallen by
32.27%
|
|
CSL - Price-sensitive ASX Announcement
Full Release
Key Points
- CSL aims to reduce annual pre-tax costs by over $500 million by FY28.
- Optimizing global plasma network to meet rising demand.
- Declining US influenza vaccination rates impacting revenue forecasts.
- New influenza vaccine manufacturing facility being opened at Tullamarine.
- Simplifying business operations to reduce complexity and enhance efficiency.
- Strategic initiatives to drive growth in plasma-derived therapies and vaccines.
- Focus on driving innovation and expanding clinical and commercial portfolios.
- Recent leadership appointments to steer transformation and growth.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| DUG Technology Ltd (DUG) ORDINARY FULLY PAID |
Information Technology |
$272 |
FY26-Q1 Business Update
|
28 Oct 2025 9:07AM |
$2.640 |
$2.010 |
fallen by
23.86%
|
|
DUG - Price-sensitive ASX Announcement
Full Release
Key Points
- Total revenue for FY26-Q1 was US$16.7 million, up 19% from FY25-Q1.
- HPC revenues grew by 40% due to increased activity from existing clients.
- Services revenue increased by 21%, while software revenue remained flat.
- A record SaaS and HPCaaS contract was signed but no revenue from it was recognized in FY26-Q1.
- First revenue from Brazil and growth in the Middle East were achieved.
- EBITDA for FY26-Q1 was US$4.2 million, up 65% from FY25-Q1.
- Operating cash inflow was US$0.4 million, an increase of US$1.1 million from the previous year.
- Total cash reserves at the end of the quarter were US$12.5 million with a net debt of US$5.7 million.
- Services Order Book valued at US$51.9 million, a 46% increase from September 2024.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| NH3 Clean Energy Limited (NH3) ORDINARY FULLY PAID |
Materials |
$58 |
WA Government Lead Agency Approval for WAH2 Project
|
28 Oct 2025 9:06AM |
$0.097 |
$0.081 |
fallen by
16.49%
|
|
NH3 - Price-sensitive ASX Announcement
Full Release
Key Points
- NH3 Clean Energy Limited received WA Government Lead Agency Approval for the WAH2 Project.
- The Lead Agency Framework streamlines approvals and facilitates efficient project progress.
- WAH2 Project aims to supply low-emissions ammonia to Asia-Pacific economies, including Japan and South Korea.
- The project is located in a Strategic Industrial Area and aligns with WA's initiatives to decarbonize and diversify the economy.
- All FEED workstreams of the WAH2 Project are targeted for completion by the end of 2026.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| BETR Entertainment Limited (BBT) ORDINARY FULLY PAID |
Consumer Discretionary |
$214 |
Notice of Annual General Meeting/Proxy Form
|
28 Oct 2025 9:06AM |
$0.235 |
$0.205 |
fallen by
12.77%
|
|
| Global Health Limited (GLH) ORDINARY FULLY PAID |
Health Care |
$4 |
GLH 4C September 25 QTR Cash Flow Report
|
28 Oct 2025 9:04AM |
$0.100 |
$0.067 |
fallen by
33%
|
|
GLH - Price-sensitive ASX Announcement
Full Release
Key Points
- Receipts from customers: $2,362,000
- Net cash outflow from operations: $1,065,000
- End of quarter cash balance: $439,000
- Delayed R&D refund affecting cash flow
- No significant investing activities
- Net inflow from financing activities: $137,000
- Payments to related parties: $91,000
- AI leverage for operational efficiency
- Future financial strategies and obligations
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Clime Capital Limited (CAM) ORDINARY FULLY PAID |
Financials |
$102 |
Update - Notification of buy-back - CAM
|
28 Oct 2025 9:04AM |
$0.680 |
$0.715 |
risen by
5.15%
|
|
| Resouro Strategic Metals Inc (RAU) CHESS DEPOSITARY INTERESTS 1:1 |
Materials |
$10 |
Becoming a substantial holder
|
28 Oct 2025 9:04AM |
$0.265 |
$0.265 |
fallen by
0%
|
|
| Alvo Minerals Limited (ALV) ORDINARY FULLY PAID |
Materials |
$6 |
Zinc-Copper Potential Confirmed at Touro Prospect, Palma
|
28 Oct 2025 9:03AM |
$0.028 |
$0.025 |
fallen by
10.71%
|
|
ALV - Price-sensitive ASX Announcement
Full Release
Key Points
- Newly discovered Touro Prospect at Palma Cu-Zn Project confirmed for zinc-copper potential.
- Auger drilling and FLEM surveys at Touro reveal consistent Zn, Cu, and Pb anomalies.
- Alvo holds a district scale landholding over 1,000 km² with multiple prospects.
- Palma hosts a JORC 2012 Mineral Resource Estimate of 7.6Mt @ 2% CuEq.
- Touro is positioned as the highest priority drill target for Alvo.
- Touro's mineralised trend extends for over 1km with high-grade gossan occurrences.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Sunshine Metals Limited (SHN) ORDINARY FULLY PAID |
Materials |
$75 |
Quarterly Activities Report
|
28 Oct 2025 9:03AM |
$0.024 |
$0.029 |
risen by
20.83%
|
|
SHN - Price-sensitive ASX Announcement
Full Release
Key Points
- Diamond drilling commenced at Sybil with multiple epithermal veins intersected.
- High-grade gold results were reported at Francis Creek.
- Liontown studies are advancing with resource updates and mining studies.
- $5 million placement to fund drilling and studies.
- Board restructuring to focus on Queensland operations.
- Cash reserves at the end of the quarter were approximately $5.1 million.
- The strategic shift to a Queensland-based Board with new appointments.
- Fieldwork at Francis Creek confirmed classic epithermal textures.
- The company's resource inventory includes Greater Liontown VMS and Plateau Resources.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| WT Financial Group Limited (WTL) ORDINARY FULLY PAID |
Financials |
$44 |
Notice of Annual General Meeting/Proxy Form
|
28 Oct 2025 9:03AM |
$0.160 |
$0.130 |
fallen by
18.75%
|
|
| Resouro Strategic Metals Inc (RAU) CHESS DEPOSITARY INTERESTS 1:1 |
Materials |
$10 |
Resouro Engages Market Maker Services
|
28 Oct 2025 9:02AM |
$0.265 |
$0.265 |
fallen by
0%
|
|
RAU - Price-sensitive ASX Announcement
Full Release
Key Points
- Resouro Strategic Metals Inc. engages Independent Trading Group INC. to provide market-making services.
- The engagement is subject to regulatory approval and complies with TSX Venture Exchange policies.
- Independent Trading Group INC. will receive a $7,000 monthly fee for their services.
- The agreement is initially for one month and automatically renews unless terminated with 30 days’ notice.
- The market-making services aim to enhance market depth and contribute to liquidity by entering orders on both sides of the book.
- Resouro is a mineral exploration and development company focused on projects in Brazil, namely the Tiros Titanium-Rare Earths Project and the Novo Mundo Gold Project.
- The Tiros project comprises 28 mineral concessions with significant resource estimates in titanium dioxide and rare earths oxides.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| OD6 Metals Limited (OD6) ORDINARY FULLY PAID |
Materials |
$26 |
Quarterly Activities/Appendix 5B Cash Flow Report
|
28 Oct 2025 9:00AM |
$0.069 |
$0.098 |
risen by
42.03%
|
|
OD6 - Price-sensitive ASX Announcement
Full Release
Key Points
- OD6 Metals Limited ended the quarter with A$3.045 million in cash.
- Operating cash flow was negative A$133,000 due to exploration and administrative costs.
- A$2.5 million was raised to support project developments.
- The Splinter Rock Rare Earth Project received significant focus with ongoing testwork and drilling.
- Gulf Creek Copper Project drilling targeted unexplored prospects.
- Innovative process flowsheets are being developed for better project economics.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Algorae Pharmaceuticals Limited (1AI) ORDINARY FULLY PAID |
Health Care |
$29 |
Quarterly Activities Report /Appendix 4C Cash Flow Statement
|
28 Oct 2025 9:00AM |
$0.010 |
$0.017 |
risen by
70%
|
|
1AI - Price-sensitive ASX Announcement
Full Release
Key Points
- Executed licensing agreement with Sakar Healthcare Ltd for oncology generics in Australia and New Zealand.
- Signed a binding term sheet with Cadila Pharmaceuticals Ltd for launching generics in cardiovascular and metabolic markets.
- Appointed Mr David Gulland as Chief Operating Officer.
- Advanced AlgoraeOS Version 2.0 for AI drug discovery with multi-GPU architecture.
- Conducted lab-in-the-loop validation with Peter MacCallum Cancer Centre.
- Progressed pre-clinical development of AI-116 for Dementia and AI-168 for Cardiovascular.
- Net operating cash outflow for the quarter was approximately $394,957.
- Cash reserves at the end of the quarter were $1.92 million.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Tarrina Resources Limited (TR8) ORDINARY FULLY PAID |
Consumer Staple |
$6 |
Quarterly Activities/Appendix 4C Cash Flow Report
|
28 Oct 2025 8:58AM |
$0.004 |
$0.016 |
risen by
300%
|
|
TR8 - Price-sensitive ASX Announcement
Full Release
Key Points
- Completion of divestment of My Foodie Box meal kit business.
- Binding share purchase agreement with MondoRox Pty Ltd for the acquisition of Rox 1 Pty Ltd and Rox 2 Pty Ltd.
- Prospectus lodged with ASIC to raise $5 million through a public offer.
- Shareholder approvals obtained for acquisition and public offer.
- Raised $734K during the quarter, including $500,000 from Promissory Notes.
- Net cash used in operating activities was $363K.
- Cash equivalents at the end of the period were $348K.
- Estimated quarters of funding available is less than one.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Conneqt Health Limited (CQT) ORDINARY FULLY PAID |
Health Care |
$20 |
New US Clinical Trial Contract
|
28 Oct 2025 8:58AM |
$0.034 |
$0.033 |
fallen by
2.94%
|
|
CQT - Price-sensitive ASX Announcement
Full Release
Key Points
- Awarded Phase 2b clinical trial contract with a U.S.-based company.
- Focus on therapies for hypertension and cardiovascular diseases.
- Trial commences in Q4 2025 across 30 U.S. sites.
- Contract valued at approximately A$1.1 million.
- Provision of SphygmoCor® XCEL and Oscar 2 ABPM systems.
- Includes setup, training, and data management services.
- Highlights Conneqt's precision and scalability in cardiovascular studies.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Australian Foundation Investment Company Limited (AFI) ORDINARY FULLY PAID |
Financials |
$8,320 |
Update - Notification of buy-back - AFI
|
28 Oct 2025 8:57AM |
$7.380 |
$6.640 |
fallen by
10.03%
|
|
| AMCIL Limited (AMH) ORDINARY FULLY PAID |
Financials |
$291 |
Update - Notification of buy-back - AMH
|
28 Oct 2025 8:56AM |
$1.090 |
$0.920 |
fallen by
15.60%
|
|
| Earlypay Ltd (EPY) ORDINARY FULLY PAID |
Financials |
$39 |
Update - Notification of buy-back - EPY
|
28 Oct 2025 8:56AM |
$0.210 |
$0.150 |
fallen by
28.57%
|
|
Call 1300 880 160
Start a chat
Schedule a call
